Objective Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with poor outcomes in patients with Crohn's disease (CD), the clinical relevance of ATI in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results